WNT4 and Mayer-Rokitansky-Kuster-Hauser syndrome: Thus, according to one study, the absence of a WNT4 mutation in four adolescent girls with MRKH syndrome and clinical and biochemical hyperandrogenism strongly suggests the potential involvement of other constituents of the Wnt4/β-catenin signaling pathway [10].